What these medicines do
GLP-1 receptor agonists mimic a gut hormone involved in appetite, stomach emptying and blood-sugar regulation. Ozempic is a semaglutide product used for type 2 diabetes, while Wegovy is a semaglutide product approved for chronic weight management in certain people. Other medicines in this family have different indications, so brand names are not interchangeable.
Who may be considered
Weight-management medicines are generally considered when excess weight is affecting health and lifestyle measures alone have not been enough. Eligibility depends on body-mass index, related conditions, age, pregnancy plans, medical history and the specific medicine. A clinician should also review other medications and possible causes of weight change.
Common side effects
Nausea, vomiting, diarrhea, constipation and abdominal discomfort are common, especially while the dose is being increased. Persistent vomiting, dehydration, severe abdominal pain or symptoms of gallbladder disease need medical assessment. People with certain endocrine or gastrointestinal conditions may need a different option.
What happens if you stop
Appetite and weight can return after treatment stops. Long-term plans usually combine medication, nutrition, physical activity, sleep and follow-up rather than treating the medicine as a temporary crash-diet tool.
Avoid unsafe shortcuts
Do not buy prescription injections from unverified sellers or change the dose without medical supervision. If a product is compounded or purchased online, verify the source and discuss it with a qualified clinician.